C83.390 Code facturable et spécifique Primary central nervous system lymphoma

ICD-10-CM C83.390 identifies “Primary central nervous system lymphoma” as a billable/specific code in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.

Chapitre 2: Neoplasms

Instructions du code

Inclusion terms4
  • PCNSL of brain
  • PCNSL of meninges
  • PCNSL of spinal cord
  • PCNSL NOS
Excludes 14
  • Primary central nervous system lymphoma, Burkitt (C83.79)
  • Primary central nervous system lymphoma, lymphoblastic (C83.59)
  • Primary central nervous system lymphoma, other (C83.89)
  • Primary central nervous system lymphoma, peripheral T-cell (C84.49)

Instructions des niveaux supérieurs

Chapitres 2 · Neoplasms (C00-D49)

Note8
  • Functional activity
  • All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
  • Morphology [Histology]
  • Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
  • Primary malignant neoplasms overlapping site boundaries
  • A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
  • Malignant neoplasm of ectopic tissue
  • Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).

C81-C96 · Malignant neoplasms of lymphoid, hematopoietic and related tissue (C81-C96)

Excludes 24
  • Kaposi's sarcoma of lymph nodes (C46.3)
  • secondary and unspecified neoplasm of lymph nodes (C77.-)
  • secondary neoplasm of bone marrow (C79.52)
  • secondary neoplasm of spleen (C78.89)

C83 · Non-follicular lymphoma

Excludes 11

personal history of non-Hodgkin lymphoma (Z85.72)

C83.3 · Diffuse large B-cell lymphoma

Inclusion terms7
  • Anaplastic diffuse large B-cell lymphoma
  • CD30-positive diffuse large B-cell lymphoma
  • Centroblastic diffuse large B-cell lymphoma
  • Diffuse large B-cell lymphoma, subtype not specified
  • Immunoblastic diffuse large B-cell lymphoma
  • Plasmablastic diffuse large B-cell lymphoma
  • T-cell rich diffuse large B-cell lymphoma
Excludes 12
  • mediastinal (thymic) large B-cell lymphoma (C85.2-)
  • mature T/NK-cell lymphomas (C84.-)
Références de l’index officiel

Références de l’index officiel (3)

Lymphoma(of) (malignant) (3)

Historique officiel de conversion

Historical assignments from the CDC conversion table support data retrieval. They do not authorize substituting a previous code for the current code.

Dates de validité 2024-10-01

Attribution précédente: Z85.72

Historique

Historique du code

Dernière modification enregistrée · FY2025

ModifiéInchangé
FY2025

En vigueur dès le

  • Ajouté

Primary central nervous system lymphoma

Code de diagnostic facturable

CDC/NCHS · FY2025

Toutes les éditions (5)

Toutes les éditionsEn vigueur dès leHistorique du code
FY20252024-10-01Ajouté
FY2025 · 04-012025-04-01Aucun changement tabulaire
FY20262025-10-01Aucun changement tabulaire
FY2026 · April2026-04-01Aucun changement tabulaire
FY20272026-10-01Aucun changement tabulaire

Cette entrée est un code complet dans l’édition sélectionnée. La vérification du référentiel ne confirme pas la pertinence clinique et ne garantit pas le remboursement.